Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Gencors managing director and founder Ramasamy Venkatesh first revealed to NutraIngredients-Asia last September that the company has been researching on an ingredient which could potentially serve as an alternative to GLP-1 or glucagon-like peptide-1 drugs
Read on as we unpack the side effects of GLP-1 RAs as well as practical steps you can take to manage them
doi:10.1136/bmj-2023-078852 Jensen RB, Viuff AC, Pedersen LH, et al
Long-term urinary health on GLP-1 therapy Most discussions about semaglutide and UTIs focus on the short-term risks
US$ 26.59
US$ 27.10
US$ 23.89
US$ 22.65
US$ 29.20
US$ 23.17
US$ 27.63
US$ 24.58
